Lung Unit: For healthcare professionals
The Lung Unit at The Royal Marsden comprises a team of clinical staff specialising in medicine, radiotherapy and diagnostic imaging.
Information for GPs
The Lung Unit at The Royal Marsden does not take standard two-week referrals as we do not offer a lung cancer diagnostic service. The Royal Marsden is a treatment centre only for lung cancer and the majority of our patients have already been diagnosed. However, we do carry out further tests and investigations as required.
GPs refer new patients to other trusts for a diagnostic work-up. Other trusts can then refer patients with a diagnosis of lung cancer to The Royal Marsden.
Existing patients who are not undergoing active treatment normally have a follow-up every three months. If these patients have concerns in the meantime, they are advised to visit their GP, who can then refer them.
Which NHS trusts can refer to the Lung Unit?
Our partnership trusts include Epsom and St Helier NHS Trust, Kingston Hospital, Croydon University Hospital, St George's Hospital and The Royal Brompton Hospital. Our consultants attend weekly MDT meetings at these hospitals to discuss their patients.
The unit receives a high number of requests for second opinions. These are all reviewed by a consultant but often only patients who they feel may be suitable for a treatment that is not standard practice, such as a clinical trial, will be offered an appointment.
Features of the Lung Unit
Lung cancer includes non-small cell, small cell, mesothelioma, thymoma and neuroendocrine tumours. The Lung Unit is part of the South West Thames (Surrey) and the West London (London) lung cancer network. We can provide:
- an acute oncology service to patients in the local networks trusts
- access to PET scanning and other advanced imaging techniques
- access to the latest radiotherapy techniques, including Stereotactic/CyberKnife and IMRT
- state-of-the-art chemotherapy, including novel agent trials and adjuvant therapy
- surgery in partnership with other hospitals
- treatment using tyrosine kinase inhibitors (TKIs)
- mutation testing
- critical care
- rehabilitation and supportive treatments for dyspnoea
- palliative and supportive care
Find out more about treatments at The Royal Marsden.
GPs and other trusts are able to refer patients to The Royal Marsden for the consideration of clinical drug trials. These referrals should be sent directly to the consultant.
Find out more about clinical trials at The Royal Marsden.
We place a high priority on drug development and new treatment strategies and are actively involved in national multi-centre trials to evaluate therapies, particularly in patients with early stage disease.
We have an active research programme in Stereotactic/IMRT/CyberKnife radiotherapy and associated support in radiotherapy, as well as ongoing genetic work.
Find out more about research at The Royal Marsden.